MOOLEC SCIENCE (MLEC)
(Delayed Data from NSDQ)
$1.01 USD
-0.02 (-1.93%)
Updated Jul 26, 2024 03:32 PM ET
After-Market: $1.02 +0.01 (0.98%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MLEC 1.01 -0.02(-1.93%)
Will MLEC be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for MLEC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MLEC
Down -18.03% in 4 Weeks, Here's Why You Should You Buy the Dip in Moolec Science SA (MLEC)
MLEC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MLEC
Buy Rating Affirmed: Moolec Science Poised for Growth with Strategic Partnerships and Strong Market Potential
Moolec Science Reports Reduced Year-Over-Year Losses
Warning: MLEC is at high risk of performing badly
Moolec Science’s Strong Q3 Financials and Strategic Developments Underpin Buy Rating
Moolec Science’s Strong Growth in Q3 FY2024